TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
SLDB

Solid Biosciences LLC

Healthcare · Biotechnology

7.30$ -2.5% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow SLDB
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – – – – –
– +0.0% +700.0% +249.6% +80.3% +38.9% -24.4% -18.8% +7.2% -4.9% -176.3%
– +92.4% +262.6% +11.7% +138.6% -18.1% +15.0% -43.6% +1.2% +38.0% +60.8%
– -343.1% – +48.3% +138.4% -18.3% +16.0% -44.0% – – –
– +75.4% +59.0% -164.0% – +108.4% -242.6% – – – -339.4%
– +0.0% +480.6% +241.7% -43.6% -79.5% +42.5% +135.4% -49.8% -56.8% +76.3%
– -84.3% – -353.7% – -73.1% -1,480.1% – -83.6% -266.0% +263.4%
– -50.0% +2,224.6% +65.4% -56.0% -66.7% +599.7% -46.2% -100.0% – -67.1%
– +0.0% +0.0% +0.0% – – – – -100.0% – +52.9%
– -93.4% +2,153.7% +70.6% -56.0% +122.4% +4.9% -44.6% -95.8% +3,821.7% +58.8%
– -201.6% – -22.2% -129.9% – -143.0% – -326.0% – -420.2%
– – – – – – – – – – –

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?